Hussman Strategic Advisors, Inc. Aurinia Pharmaceuticals Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 126,000 shares of AUPH stock, worth $1.88 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
126,000
Previous 357,000
64.71%
Holding current value
$1.88 Million
Previous $3.02 Million
53.95%
% of portfolio
0.32%
Previous 0.74%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
255Shares Held
61.1MCall Options Held
977KPut Options Held
616K-
Tang Capital Management LLC San Diego, CA10MShares$149 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$138 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$59.1 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$41.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$35.7 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.11B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...